CV Lattes
ORCID
Abstract
Myelodysplastic syndrome (MDS) is a bone marrow disease that affects the production of blood cells, with a risk of developing into acute myeloid leukemia. Treatment options are limited, highlighting the need for alternative therapies. Compounds derived from green tea, such as (-)-epigallocatechin-3-gallate (EGCG), have shown therapeutic potential in leukemia models. However, their effect …